New Scaffold against Estrogen Receptor to Inhibit in Breast Cancer
8 Angebote vergleichen
| Preise | Juni 16 | Nov. 16 | Mai 19 |
|---|---|---|---|
| Schnitt | € 35,90 | € 34,61 | € 39,07 |
| Nachfrage |
1
Symbolbild
New Scaffold against Estrogen Receptor to Inhibit in Breast Cancer
EN PB NWISBN: 9783659875922 bzw. 3659875929, in Englisch, LAP Lambert Academic Publishing, Taschenbuch, neu.
Estrogen receptors (ER) are overexpressed in human breast cancers and associated with differentiated tumors with a more favorable prognosis. Paradoxically, these receptors mediate the mitogenic action of estrogens in human breast cancer cells and the efficacy of antiestrogens in adjuvant therapy of primary tumors. The mode of action of overexpression.Estrogen receptors (ER) protein plays a critical role for causing the breast cancer. The exact mechanism underlying the ER protection against cancer progression to metastasis remains to be investigated. Here in this study we show that Pharmacophores of Diethylstilbestrol and other four drugs molecules were designed and screened. The main objective of this study is to design a New scaffold to block the estrogen receptor through 'Molecular Docking approach' by using the In silico tools. Further, Chemical Diversity and ADME screening are also desired which increase our ability to predict and model the most relevant pharmacokinetic and metabolic endpoints, thereby accelerating the drug discovery process.
2
New Scaffold against Estrogen Receptor to Inhibit in Breast Cancer
~EN PB NWISBN: 9783659875922 bzw. 3659875929, vermutlich in Englisch, 72 Seiten, LAP Lambert Academic Publishing, Taschenbuch, neu.
Lieferung aus: Deutschland, Versandkosten nach: Deutschland.
Von Händler/Antiquariat, Rheinberg-Buch, [3813847].
Neuware - Estrogen receptors (ER) are overexpressed in human breast cancers and associated with differentiated tumors with a more favorable prognosis. Paradoxically, these receptors mediate the mitogenic action of estrogens in human breast cancer cells and the efficacy of antiestrogens in adjuvant therapy of primary tumors. The mode of action of overexpression.Estrogen receptors (ER) protein plays a critical role for causing the breast cancer. The exact mechanism underlying the ER protection against cancer progression to metastasis remains to be investigated. Here in this study we show that Pharmacophores of Diethylstilbestrol and other four drugs molecules were designed and screened. The main objective of this study is to design a New scaffold to block the estrogen receptor through 'Molecular Docking approach' by using the In silico tools. Further, Chemical Diversity and ADME screening are also desired which increase our ability to predict and model the most relevant pharmacokinetic and metabolic endpoints, thereby accelerating the drug discovery process. Taschenbuch, Neuware, 220x150x4 mm, 124g, 72, Internationaler Versand, PayPal, offene Rechnung, Banküberweisung, sofortueberweisung.de.
Von Händler/Antiquariat, Rheinberg-Buch, [3813847].
Neuware - Estrogen receptors (ER) are overexpressed in human breast cancers and associated with differentiated tumors with a more favorable prognosis. Paradoxically, these receptors mediate the mitogenic action of estrogens in human breast cancer cells and the efficacy of antiestrogens in adjuvant therapy of primary tumors. The mode of action of overexpression.Estrogen receptors (ER) protein plays a critical role for causing the breast cancer. The exact mechanism underlying the ER protection against cancer progression to metastasis remains to be investigated. Here in this study we show that Pharmacophores of Diethylstilbestrol and other four drugs molecules were designed and screened. The main objective of this study is to design a New scaffold to block the estrogen receptor through 'Molecular Docking approach' by using the In silico tools. Further, Chemical Diversity and ADME screening are also desired which increase our ability to predict and model the most relevant pharmacokinetic and metabolic endpoints, thereby accelerating the drug discovery process. Taschenbuch, Neuware, 220x150x4 mm, 124g, 72, Internationaler Versand, PayPal, offene Rechnung, Banküberweisung, sofortueberweisung.de.
3
New Scaffold against Estrogen Receptor to Inhibit in Breast Cancer
~EN PB NWISBN: 9783659875922 bzw. 3659875929, vermutlich in Englisch, Taschenbuch, neu.
Von Händler/Antiquariat, BookSupply International [50929779], Solihull, WMID, United Kingdom.
Publisher/Verlag: LAP Lambert Academic Publishing | Estrogen receptors (ER) are overexpressed in human breast cancers and associated with differentiated tumors with a more favorable prognosis. Paradoxically, these receptors mediate the mitogenic action of estrogens in human breast cancer cells and the efficacy of antiestrogens in adjuvant therapy of primary tumors. The mode of action of overexpression.Estrogen receptors (ER) protein plays a critical role for causing the breast cancer. The exact mechanism underlying the ER protection against cancer progression to metastasis remains to be investigated. Here in this study we show that Pharmacophores of Diethylstilbestrol and other four drugs molecules were designed and screened. The main objective of this study is to design a New scaffold to block the estrogen receptor through 'Molecular Docking approach' by using the In silico tools. Further, Chemical Diversity and ADME screening are also desired which increase our ability to predict and model the most relevant pharmacokinetic and metabolic endpoints, thereby accelerating the drug discovery process. | Format: Paperback | Language/Sprache: english | 72 pp.
Publisher/Verlag: LAP Lambert Academic Publishing | Estrogen receptors (ER) are overexpressed in human breast cancers and associated with differentiated tumors with a more favorable prognosis. Paradoxically, these receptors mediate the mitogenic action of estrogens in human breast cancer cells and the efficacy of antiestrogens in adjuvant therapy of primary tumors. The mode of action of overexpression.Estrogen receptors (ER) protein plays a critical role for causing the breast cancer. The exact mechanism underlying the ER protection against cancer progression to metastasis remains to be investigated. Here in this study we show that Pharmacophores of Diethylstilbestrol and other four drugs molecules were designed and screened. The main objective of this study is to design a New scaffold to block the estrogen receptor through 'Molecular Docking approach' by using the In silico tools. Further, Chemical Diversity and ADME screening are also desired which increase our ability to predict and model the most relevant pharmacokinetic and metabolic endpoints, thereby accelerating the drug discovery process. | Format: Paperback | Language/Sprache: english | 72 pp.
4
New Scaffold against Estrogen Receptor to Inhibit in Breast Cancer (2016)
EN PB NWISBN: 9783659875922 bzw. 3659875929, in Englisch, 72 Seiten, LAP LAMBERT Academic Publishing, Taschenbuch, neu.
Neu ab: $34.42 (5 Angebote)
Zu den weiteren 5 Angeboten bei Amazon.com
Lieferung aus: Vereinigte Staaten von Amerika, Usually ships in 1-2 business days.
Von Händler/Antiquariat, Book Depository US.
Estrogen receptors (ER) are overexpressed in human breast cancers and associated with differentiated tumors with a more favorable prognosis. Paradoxically, these receptors mediate the mitogenic action of estrogens in human breast cancer cells and the efficacy of antiestrogens in adjuvant therapy of primary tumors. The mode of action of overexpression.Estrogen receptors (ER) protein plays a critical role for causing the breast cancer. The exact mechanism underlying the ER protection against cancer progression to metastasis remains to be investigated. Here in this study we show that Pharmacophores of Diethylstilbestrol and other four drugs molecules were designed and screened. The main objective of this study is to design a New scaffold to block the estrogen receptor through ‘Molecular Docking approach’ by using the In silico tools. Further, Chemical Diversity and ADME screening are also desired which increase our ability to predict and model the most relevant pharmacokinetic and metabolic endpoints, thereby accelerating the drug discovery process. Paperback, Label: LAP LAMBERT Academic Publishing, LAP LAMBERT Academic Publishing, Produktgruppe: Book, Publiziert: 2016-04-26, Freigegeben: 2016-04-26, Studio: LAP LAMBERT Academic Publishing.
Von Händler/Antiquariat, Book Depository US.
Estrogen receptors (ER) are overexpressed in human breast cancers and associated with differentiated tumors with a more favorable prognosis. Paradoxically, these receptors mediate the mitogenic action of estrogens in human breast cancer cells and the efficacy of antiestrogens in adjuvant therapy of primary tumors. The mode of action of overexpression.Estrogen receptors (ER) protein plays a critical role for causing the breast cancer. The exact mechanism underlying the ER protection against cancer progression to metastasis remains to be investigated. Here in this study we show that Pharmacophores of Diethylstilbestrol and other four drugs molecules were designed and screened. The main objective of this study is to design a New scaffold to block the estrogen receptor through ‘Molecular Docking approach’ by using the In silico tools. Further, Chemical Diversity and ADME screening are also desired which increase our ability to predict and model the most relevant pharmacokinetic and metabolic endpoints, thereby accelerating the drug discovery process. Paperback, Label: LAP LAMBERT Academic Publishing, LAP LAMBERT Academic Publishing, Produktgruppe: Book, Publiziert: 2016-04-26, Freigegeben: 2016-04-26, Studio: LAP LAMBERT Academic Publishing.
5
New Scaffold against Estrogen Receptor to Inhibit in Breast Cancer
~EN PB NWISBN: 3659875929 bzw. 9783659875922, vermutlich in Englisch, LAP Lambert Academic Publishing, Taschenbuch, neu.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
7
New Scaffold against Estrogen Receptor to Inhibit in Breast Cancer (2016)
EN PB NWISBN: 9783659875922 bzw. 3659875929, in Englisch, 72 Seiten, LAP LAMBERT Academic Publishing, Taschenbuch, neu.
Neu ab: € 35,89 (9 Angebote)
Zu den weiteren 9 Angeboten bei Amazon.de (Int.)
Lieferung aus: Deutschland, Gewöhnlich versandfertig in 24 Stunden, Versandkostenfrei. Tatsächliche Versandkosten können abweichen.
Von Händler/Antiquariat, averdo24.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Von Händler/Antiquariat, averdo24.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
8
New Scaffold against Estrogen Receptor to Inhibit in Breast Cancer (2016)
~EN NWISBN: 3659875929 bzw. 9783659875922, vermutlich in Englisch, LAP Lambert Academic Publishing, neu.
Von Händler/Antiquariat, MARZIES.de Buch- und Medienhandel, 14621 Schönwalde-Glien.
Kartoniert / Broschiert, neu, 2017-10-25.
Kartoniert / Broschiert, neu, 2017-10-25.
Lade…